It is a white crystalline powder with anti - tumor and anti - mitosis effect. The molecular formula is C43H53NO14, CAS number is 114977-28-5

Market Analysis and Insights: Global Docetaxel Anhydrous API Market
The global Docetaxel Anhydrous API market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Docetaxel Anhydrous API Scope and Market Size
The global Docetaxel Anhydrous API market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Docetaxel Anhydrous API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Purity ≥ 95 %
Purity ≥ 98 %

Segment by Application
Docetaxel Anhydrous Injection
Other

The Docetaxel Anhydrous API market is analysed and market size information is provided by regions (countries). Segment by Application, the Docetaxel Anhydrous API market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Phyton Biotech
Scion Pharm Taiwan
Aspen Biopharma Labs
Arca Pharmalabs
Fresenius Kabi Oncology
Dr. Reddy's Laboratories
Fujian South Pharmaceutical
Hainan Yew Pharmaceutical
Hubei Haosun Pharmaceutical
Tecoland
Qilu Pharmaceutial
Berr Chemical